Evidence map›Paper›PMID 39001416›Full record

ArticleCancers2024

Cell State Transition Models Stratify Breast Cancer Cell Phenotypes and Reveal New Therapeutic Targets.

Oleksii S Rukhlenko, Hiroaki Imoto, Ayush Tambde, Amy McGillycuddy, Philipp Junk, Anna Tuliakova, Walter Kolch, Boris N Kholodenko

Abstract read
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Oleksii S RukhlenkoSystems Biology Ireland, School of Medicine, University College Dublin, D04 V1W8 Dublin, Ireland.
Hiroaki ImotoSystems Biology Ireland, School of Medicine, University College Dublin, D04 V1W8 Dublin, Ireland.ORCID 0000-0002-6817-642X
Ayush TambdeSystems Biology Ireland, School of Medicine, University College Dublin, D04 V1W8 Dublin, Ireland.
Amy McGillycuddySystems Biology Ireland, School of Medicine, University College Dublin, D04 V1W8 Dublin, Ireland.
Philipp JunkSystems Biology Ireland, School of Medicine, University College Dublin, D04 V1W8 Dublin, Ireland.
Anna TuliakovaSystems Biology Ireland, School of Medicine, University College Dublin, D04 V1W8 Dublin, Ireland.ORCID 0009-0006-3508-5085
Walter KolchSystems Biology Ireland, School of Medicine, University College Dublin, D04 V1W8 Dublin, Ireland.ORCID 0000-0001-5777-5016
Boris N KholodenkoSystems Biology Ireland, School of Medicine, University College Dublin, D04 V1W8 Dublin, Ireland.ORCID 0000-0002-9483-4975

Funding

Multiscale Modeling to Optimize Inhibition of Oncogenic ERK Pathway SignalingR01CA244660 · NCI · YALE UNIVERSITY · PI HLAVACEK, WILLIAM S, KHOLODENKO, BORIS N · 2020 to 2024
$3.4M
EU 101136926 MULTIRJSPS Overseas Research FellowshipsNational Children's Research Centre/Children's Health Ireland 22/FFP-A/10729NCI NIH HHS R01 CA244660NIH HHS R01CA244660Science Foundation Ireland 18/RI/5702Science Foundation Ireland 18/SPP/3522Science Foundation Ireland 22/PATH-S/10875
6 · The paper itself

Abstract

Understanding signaling patterns of transformation and controlling cell phenotypes is a challenge of current biology. Here we applied a cell State Transition Assessment and Regulation (cSTAR) approach to a perturbation dataset of single cell phosphoproteomic patterns of multiple breast cancer (BC) and normal breast tissue-derived cell lines. Following a separation of luminal, basal, and normal cell states, we identified signaling nodes within core control networks, delineated causal connections, and determined the primary drivers underlying oncogenic transformation and transitions across distinct BC subtypes. Whereas cell lines within the same BC subtype have different mutational and expression profiles, the architecture of the core network was similar for all luminal BC cells, and mTOR was a main oncogenic driver. In contrast, core networks of basal BC were heterogeneous and segregated into roughly four major subclasses with distinct oncogenic and BC subtype drivers. Likewise, normal breast tissue cells were separated into two different subclasses. Based on the data and quantified network topologies, we derived mechanistic cSTAR models that serve as digital cell twins and allow the deliberate control of cell movements within a Waddington landscape across different cell states. These cSTAR models suggested strategies of normalizing phosphorylation networks of BC cell lines using small molecule inhibitors.

Indexed as

breast cancercSTARdigital twinsmachine learningmathematical modelingnetwork reconstructionsignaling networks

Identifiers

PMID39001416
PMCPMC11240448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.